Higher Dose Imatinib for Children With De Novo Chronic Phase Chronic Myelogenous Leukemia: A Report From the Children’s Oncology Group

PURPOSE: To determine the efficacy of imatinib in children with newly diagnosed chronic phase (CP) chronic myelogenous leukemia (CML). METHODS: This was an open label, multi-center phase II clinical trial. Courses were defined as consecutive 28-day intervals. Oral imatinib was administered daily at...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Blood Cancer
Main Authors: Champagne, Martin A., Fu, Cecilia H., Chang, Myron, Chen, Helen, Gerbing, Robert B., Alonzo, Todd A., Cooley, Linda D., Heerema, Nyla A., Oehler, Vivian, Wood, Charlotte, French, Mary Ellen, Arceci, Robert J., Smith, Franklin O., Bernstein, Mark L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5157124/
https://ncbi.nlm.nih.gov/pubmed/21465636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.23031
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados